Inflammatory rhabdomyoblastic tumor, pheochromocytoma, and pulmonary hamartoma in a patient with neurofibromatosis type 1: a case report

Diagn Pathol. 2024 Jun 11;19(1):78. doi: 10.1186/s13000-024-01503-3.

Abstract

Background: Inflammatory rhabdomyoblastic tumors are relatively recently recognized soft tissue tumors with a low malignant potential. Here, we present a case of concurrent inflammatory rhabdomyoblastic tumor (IRMT), adrenal pheochromocytoma, and pulmonary hamartoma in a patient with neurofibromatosis type 1 (NF1). To our knowledge, this is the first time that this constellation of tumors has been described in the literature.

Case presentation: A female patient in her late 20s with known NF1 was diagnosed with an inflammatory rhabdomyoblastic tumor, pheochromocytoma, and pulmonary hamartoma in a short succession. IRMT was found to harbor a near-haploid genome and displayed a typical immunohistochemical profile as well as a focal aberrant p53 expression pattern.

Conclusions: This case report strengthens the theory that defects in the tumor suppressor NF1 play a central role in the pathogenesis of inflammatory rhabdomyoblastic tumors and that IRMT may be part of the spectrum of neurofibromatosis type 1 related tumors.

Keywords: Inflammatory rhabdomyoblastic tumor; Neurofibromatosis type 1; Pheochromocytoma; Pulmonary hamartoma.

Publication types

  • Case Reports

MeSH terms

  • Adrenal Gland Neoplasms* / complications
  • Adrenal Gland Neoplasms* / diagnosis
  • Adrenal Gland Neoplasms* / pathology
  • Adult
  • Biomarkers, Tumor / analysis
  • Biomarkers, Tumor / genetics
  • Female
  • Hamartoma* / diagnosis
  • Hamartoma* / pathology
  • Humans
  • Immunohistochemistry
  • Lung Diseases / diagnosis
  • Lung Diseases / pathology
  • Neurofibromatosis 1* / complications
  • Neurofibromatosis 1* / diagnosis
  • Neurofibromatosis 1* / pathology
  • Neurofibromin 1 / genetics
  • Pheochromocytoma* / complications
  • Pheochromocytoma* / diagnosis
  • Pheochromocytoma* / pathology

Substances

  • Neurofibromin 1
  • Biomarkers, Tumor